Watchlist Price Alert

Neuphoria Therapeutics In... (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

6.69

-0.01 (-0.15%)

At close: Jun 17, 2025, 1:38 PM

Neuphoria Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Net Income	-15.49M	-21.38M	-14.97M	-6.53M	-4.89M	n/a	n/a	n/a
Depreciation & Amortization	662.99K	663.19K	763.17K	1.28M	1.68M	n/a	n/a	n/a
Stock-Based Compensation	814.81K	1.35M	1.95M	983.01K	38.03K	n/a	n/a	n/a
Other Working Capital	351.28K	447.29K	157.44K	-294.75K	83.39K	n/a	n/a	n/a
Other Non-Cash Items	-2.12M	150.97K	1.15M	-2.62M	-2.28M	-10.91M	-15.02M	-1.44M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.46M	4.58M	-3.85M	1.23M	2.77M	n/a	n/a	n/a
Operating Cash Flow	-14.68M	-14.64M	-14.97M	-5.66M	-2.68M	-10.91M	-15.02M	-1.44M
Capital Expenditures	n/a	n/a	-1.06K	-1.1K	-5.29K	-69.28K	-358.11K	-190.2K
Cash Acquisitions	n/a	n/a	n/a	n/a	-692.61K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-89.01K	-35.85K	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	299.68K	n/a	377.92K	n/a	n/a	n/a
Other Investing Acitivies	n/a	317.41K	129.06K	29.85K	221.76K	207.71K	417.79K	923.25K
Investing Cash Flow	n/a	317.41K	427.68K	-60.26K	-134.08K	138.42K	59.68K	733.05K
Debt Repayment	n/a	-105.94K	-119.85K	-8.92M	-5.69M	-3.73M	1.63M	-1.71M
Common Stock Repurchased	n/a	n/a	n/a	-415.48K	-48.23K	-420.37K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5M	105.94K	-3.94M	-312.16K	-226.68K	-294.4K	n/a	0.02
Financial Cash Flow	15.11M	3.86M	18.57M	23.71M	-3.68M	3.05M	1.94M	-1.6M
Net Cash Flow	504.99K	-11.02M	3.48M	17.97M	-6.46M	-7.67M	-13.18M	-1.98M
Free Cash Flow	-14.68M	-14.64M	-14.97M	-5.67M	-2.69M	-10.98M	-15.38M	-1.3M